Protective Effects of GLP-1 on Glomerular Endothelium and Its Inhibition by PKCβ Activation in Diabetes
Akira Mima(Osaka University of Pharmaceutical Sciences), George L. King(Joslin Diabetes Center), Munehiro Kitada(Kanazawa Medical University), Christian Rask‐Madsen(University of Ulsan), Koji Mizutani(Nagoya University), Pedro Geraldes(Université de Sherbrooke), Qian Li(Joslin Diabetes Center), Chenzhong Li(Joslin Diabetes Center), Motonobu Matsumoto(Joslin Diabetes Center), Shin-Ichi Nishikawa(Unknown), Kyoungmin Park(Joslin Diabetes Center), Christopher Cahill(Joslin Diabetes Center), Junko Hiraoka-Yamomoto(Joslin Diabetes Center)
Cited by 204
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979